Atos Healthcare/Life Sciences Digital Insights

We are excited to announce our latest podcast episode where Miles Newman and Dave Berry discuss the key challenges pharmaceutical companies and healthcare face today in regards to medicines manufacturing. In this episode, Dave shares his insights on how The Medicines Manufacturing Innovation Centre is working towards solving current barriers through collaborative innovation culture and state-of the art facilities. The organization’s Grand Challenges are revolutionary strategic projects that focus on accelerating the development of new generation manufacturing processes and help companies integrate these within their existing models. Tune in to find out more about novel techniques for producing patient-centric medicines, real-time release of drugs, integrated process analytics, modular manufacturing for stratified medicine production and more.  Speakers: Miles Newman: Account Director NHSS H&LS | Atos Dave Berry: Head of Digital Business Systems - Pharma | CPI

Join us in our latest podcast episode as we delve into the world of sustainable pharma! We invited two decarbonization experts, Lauren Sugden and Rylan Urban, to provide actionable solutions for overcoming challenges pharmaceutical companies face in achieving net zero, with a sharp focus on Supply Chain issues and Climate Risk Reporting difficulties. From highlighting the best practices of leading pharma companies to discussing the latest tools, techniques and solutions, such as the Climate Risk Platform and the TCFD Gap Analysis, this episode is a must-listen for anyone looking to drive sustainability in their organization. Feel free to contact our listeners with any questions and inquiries: Lauren Sugden | LinkedIn [https://www.linkedin.com/in/laurensugden/] Rylan Urban | LinkedIn [https://www.linkedin.com/in/rylanurban/] #LifeSciences #Decarbonization #netzero #pharmaceuticals #SustainablePharma

As we look ahead to 2023, have you determined your focus areas for the healthcare industry, balancing between budgets and value delivery? Are customer engagement, edge security, and cloud capabilities at the forefront of your priorities? Additionally, are you reevaluating your company's product-centric model and exploring possibilities for greater data interoperability? In the latest episode of our podcast, Manish Mehta, Chief Technology Officer for Health and Life Sciences North America at Atos, delves into eight key areas of focus for the healthcare industry in the coming year. He provides valuable insights into what CIOs and other senior leaders in the industry are prioritizing in the year ahead. Don't miss this opportunity to gain a deeper understanding of the trends and technologies shaping the future of healthcare. Tune in now to learn more. If you found this information helpful and would like to talk to us about our solutions, please reach out to Manish on: manish.mehta@atos.net [manish.mehta@atos.net] or Manish Mehta | LinkedIn [https://www.linkedin.com/in/manishbmehta/] #CIO #CTOpriorities #Healthcarepriorities #Healthcare2023 #HealthcareandLifeSciences

Listen to our latest podcast as we speak to two professionals, Gemma Holliday and Gayle Marshall, to learn more about the different stages of drug discovery and the critical role data plays in each stage. Gemma is the Lead of Cheminformatics at Medicine Discovery Catapult, and Gayle is her colleague, Head of the Biomarkers department. Our speakers also touch upon the cutting-edge technologies utilized in drug discovery and shed light on what digital technology companies can do to facilitate these complex processes. Contact our speakers: https://md.catapult.org.uk [https://md.catapult.org.uk/] #drugdiscovery #data #technology #MedicineDiscoveryCatapult #lifesciences

Our latest thought leadership report, Unlocking Virtual Dimensions for healthcare and life sciences, discusses how healthcare and life science companies can utilize digital to expand care reach and bridge the healthcare inequity gap.  Listen to our latest episode as Mary Sirois, Global Portfolio Leader, Healthcare Provider and Payer Markets, and member of the Atos Scientific Community Governance team, shares key highlights from our report, as well as some important takeaways for healthcare and life science organizations.